Loading company…
WellDoc provides digital health solutions, including the FDA-cleared BlueStar app for managing chronic conditions such as diabetes.
WellDoc's flagship product, BlueStar, is an FDA-cleared mobile app that helps people manage chronic conditions such as Type 1 and Type 2 diabetes, hypertension, heart failure and obesity. It serves health plans, health systems, employers and partners in the US, using subscriptions and partnerships for revenue. Founded in 2005 and headquartered in Columbia, US, WellDoc raised USD 7.5 mn in a Series B round on March 1, 2016, led by Johnson & Johnson Innovation, and has completed 11 deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in